Experience
Chiron Corp.
Institut Pasteur
We represented the Institut Pasteur against the National Institutes of Health in an interference which sought to determine which party was first to discover the AIDS virus and to invent the AIDS antibody test kit. Ultimately, this high-profile, high-stakes interference was settled by the government intervention of the President of the United States and the Prime Minister of France. In another important interference for client Institut Pasteur, we challenged a patent owned by Chiron Corporation for a sensitive method of detecting HIV infection in human patients. The method has had widespread application in the diagnosis of such infections. Institut Pasteur succeeded in defending against Chiron’s attacks on its patent application and was awarded priority of invention by the PTO. This victory strengthened Institut Pasteur’s patent portfolio on HIV technology, which is licensed to benefit the public health and welfare.
Chiron Corp. v. Institut Pasteur, Int. No. 105,289, Board of Patent Appeals and Interferences, Judge Lane
Proving first-to-invent status in interference involving metal alloys
Allegheny Ludlum Co.
Interference victory for inventors of electrosurgical scissors
Boston Scientific
RCT’s method patents affirmed in Federal Circuit’s first section 101 decision since Bilski
Research Corporation Technologies, Inc.
Finnegan secures an award of priority in transdermal drug delivery interference
Minnesota Mining and Manufacturing Co.
Alliance for Sustainable Energy, LLC
Intertrust Technologies Corp. v. Macrovision, Inc.
Intertrust Technologies Corp.
Geron Corp.
Agilent Technologies Inc.
Pharmaceutical company wins judgment based on filing date
Elan Pharmaceuticals
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.